scholarly journals Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

2020 ◽  
Vol 26 (2) ◽  
pp. 117-128
Author(s):  
Carmela Benson ◽  
Bruno Emond ◽  
Hela Romdhani ◽  
Patrick Lefebvre ◽  
Aurélie Côté-Sergent ◽  
...  
Author(s):  
Philip Keiser ◽  
Naiel Nassar ◽  
Mary Beth Kvanli ◽  
Dianna Turner ◽  
James W. Smith ◽  
...  

Author(s):  
Philip Keiser ◽  
Naiel Nassar ◽  
Mary Beth Kvanli ◽  
Dianna Turner ◽  
James W. Smith ◽  
...  

2016 ◽  
Vol 95 (1) ◽  
pp. 168-174 ◽  
Author(s):  
Janna M. Schurer ◽  
Wu Zeng ◽  
Marwa Farag ◽  
Michael Schwandt ◽  
Ellen Rafferty ◽  
...  

2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Sabine Kinloch-de Loes ◽  
Lucy Dorrell ◽  
Hongbing Yang ◽  
Gareth A. D. Hardy ◽  
Sabine Yerly ◽  
...  

Abstract Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enable long-term drug-free virological control in rare individuals. We describe a female who maintained aviremia and a normal CD4+/CD8+ T cell ratio for 10 years after stopping therapy, despite a persistent viral reservoir. Cellular immune responses may have contributed to this outcome.


2016 ◽  
Vol Volume 8 ◽  
pp. 407-412 ◽  
Author(s):  
Alessandro Roggeri ◽  
Daniela Paola Roggeri ◽  
Elisa Rossi ◽  
Salvatore Cataudella ◽  
Nello Martini

2017 ◽  
Vol 67 (2) ◽  
pp. 123-129
Author(s):  
Wipawee Nittayananta ◽  
Aree Kanjanaprapas ◽  
Pratanporn Arirachakaran ◽  
Kanokporn Pangsomboon ◽  
Hutcha Sriplung

2013 ◽  
Vol 167 (6) ◽  
pp. 520 ◽  
Author(s):  
Steven E. Lipshultz ◽  
Paige L. Williams ◽  
James D. Wilkinson ◽  
Erin C. Leister ◽  
Russell B. Van Dyke ◽  
...  

2020 ◽  
Vol 28 (6) ◽  
pp. 819-823
Author(s):  
L. Trenaman ◽  
D. Stacey ◽  
S. Bryan ◽  
K. Payne ◽  
G. Hawker ◽  
...  

2019 ◽  
Vol 70 (8) ◽  
pp. 1750-1753 ◽  
Author(s):  
Sara C Auld ◽  
Pholo Maenetje ◽  
Shruthi Ravimohan ◽  
Drew Weissman ◽  
Itai Ncube ◽  
...  

Abstract End-organ impairment has received relatively little research attention as a possible manifestation of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS). In this prospective cohort study, one-half of adults with human immunodeficiency virus and pulmonary tuberculosis experienced meaningful declines in lung function on antiretroviral therapy, suggesting a role for lung function in TB-IRIS definitions.


2016 ◽  
Vol 263 (6) ◽  
pp. 1120-1128 ◽  
Author(s):  
Nete Munk Nielsen ◽  
Lise Kay ◽  
Benedikte Wanscher ◽  
Rikke Ibsen ◽  
Jakob Kjellberg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document